TOTAL S.A. (NYSE: TOT), Orexigen Therapeutics, Inc. (NASDAQ: OREX), Rovi Corp (NASDAQ: ROVI) and Unilever NLG 1.12 (NYSE: UN) upgraded by analysts.
Orexigen Therapeutics, Inc. (OREX) was upgraded by JMP Securities from a “Market Perform” rating to an “Outperform” rating.
Rovi Corp. (ROVI) was upgraded by JPMorgan Chase & Co. (NYSE:JPM) from a “Neutral” rating to an “Overweight” rating. They have a price target of $60.00 on the company.
TOTAL S.A. (NYSE: TOT) was upgraded by Credit Suisse (NYSE:CS) from an “Underperform” rating to a “Neutral” rating.
Unilever (UN) was upgraded by Jefferies (NYSE:JEF) from a “Hold” rating to a “Buy” rating. They have a price target of $36.20 on the company, up from $32.00.
No comments:
Post a Comment